These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30084408)

  • 41. Antimicrobial Susceptibility of Invasive Streptococcus pyogenes Isolates in Germany during 2003-2013.
    Imöhl M; van der Linden M
    PLoS One; 2015; 10(9):e0137313. PubMed ID: 26340445
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Macrolide and tetracycline resistance in clinical strains of Streptococcus agalactiae isolated in Tunisia.
    Hraoui M; Boutiba-Ben Boubaker I; Rachdi M; Slim A; Ben Redjeb S
    J Med Microbiol; 2012 Aug; 61(Pt 8):1109-1113. PubMed ID: 22538994
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Phenotypes and mechanisms of resistance to macrolides and lincosamides in Streptococcus agalactiae isolates with clinical significance in an eight-year period (2002-2010)].
    Campelo FA; Pedrosa AC; Antúnez IÁ; Capuz BL
    Rev Esp Quimioter; 2012 Mar; 25(1):42-6. PubMed ID: 22488541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A study on erm(B)-mediated MLS resistance in Streptococcus pyogenes clinical isolates.
    Rombini S; Petrelli D; Bolli E; Tran CN; Falconi M; Di Luca MC; Prenna M; Ripa S; Vitali LA
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):387-94. PubMed ID: 21683270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibiotic susceptibility pattern and erythromycin resistance mechanisms in beta-hemolytic group G Streptococcus dysgalactiae subspecies equisimilis isolates from central Taiwan.
    Lo HH; Nien HH; Cheng YY; Su FY
    J Microbiol Immunol Infect; 2015 Dec; 48(6):613-7. PubMed ID: 24856419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004.
    Tamayo J; Pérez-Trallero E; Gómez-Garcés JL; Alós JI;
    J Antimicrob Chemother; 2005 Oct; 56(4):780-2. PubMed ID: 16120627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clindamycin resistant emm33 Streptococcus pyogenes emerged among invasive infections in Helsinki metropolitan area, Finland, 2012 to 2013.
    Pesola AK; Sihvonen R; Lindholm L; Pätäri-Sampo A
    Euro Surveill; 2015 May; 20(18):. PubMed ID: 25990232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Macrolide resistance in group A beta haemolytic Streptococcus isolated from outpatient children in Latvia.
    Zavadska D; Bērziņa D; Drukaļska L; Pugacova N; Miklasevics E; Gardovska D
    APMIS; 2010 May; 118(5):366-70. PubMed ID: 20477812
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of macrolide-lincosamide resistance and multidrug resistance phenotypes in streptococcal isolates causing infections in European hospitals: Evaluation of the in vitro activity of oritavancin and comparator agents.
    Mendes RE; Castanheira M; Farrell DJ; Flamm RK; Sader HS; Jones RN
    J Glob Antimicrob Resist; 2017 Mar; 8():28-32. PubMed ID: 27939809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey.
    Colakoglu S; Alacam R; Hascelik G
    Scand J Infect Dis; 2006; 38(6-7):456-9. PubMed ID: 16798693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008).
    Ardanuy C; Domenech A; Rolo D; Calatayud L; Tubau F; Ayats J; Martín R; Liñares J
    J Antimicrob Chemother; 2010 Apr; 65(4):634-43. PubMed ID: 20118164
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Susceptibility of Group A Streptococcus to Antimicrobial Agents in Northern Israel: A Surveillance Study.
    Chazan B; Raz R; Edelstein H; Kennes Y; Gal V; Colodner R
    Microb Drug Resist; 2015 Oct; 21(5):551-5. PubMed ID: 26430943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular mechanisms of tetracycline and macrolide resistance and emm characterization of Streptococcus pyogenes isolates in Tunisia.
    Hraoui M; Boutiba-Ben Boubaker I; Doloy A; Ben Redjeb S; Bouvet A
    Microb Drug Resist; 2011 Sep; 17(3):377-82. PubMed ID: 21612508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Macrolide Resistance and Its Molecular Genetic Mechanisms in Streptococcus pyogenes Isolated from Children.
    Katosova LK; Lazareva AV; Khokhlova TA; Ponomarenko OA; Alyabieva NM
    Antibiot Khimioter; 2016 Aug; 61():23-29. PubMed ID: 29874449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Macrolide-lincosamide-streptogramin B resistance phenotypes in clinical staphylococcal isolates.
    Cetin ES; Gunes H; Kaya S; Aridogan BC; Demirci M
    Int J Antimicrob Agents; 2008 Apr; 31(4):364-8. PubMed ID: 18206352
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Erythromycin-Susceptible but Clindamycin-Resistant Phenotype of Clinical ermB-PCR-Positive Group B Streptococci Isolates with IS1216E-Inserted ermB.
    Moroi H; Kimura K; Ido A; Banno H; Jin W; Wachino JI; Yamada K; Kikkawa F; Park YJ; Arakawa Y
    Jpn J Infect Dis; 2019 Nov; 72(6):420-422. PubMed ID: 31257242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study.
    Betriu C; Casado MC; Gómez M; Sanchez A; Palau ML; Picazo JJ
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):255-60. PubMed ID: 10212752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
    Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
    Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates.
    Solomon K; Fanning S; McDermott S; Murray S; Scott L; Martin A; Skally M; Burns K; Kuijper E; Fitzpatrick F; Fenelon L; Kyne L
    J Antimicrob Chemother; 2011 Sep; 66(9):1976-82. PubMed ID: 21712239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Erythromycin resistance of Streptococcus pyogenes in Madrid.
    Orden B; Perez-Trallero E; Montes M; Martínez R
    Pediatr Infect Dis J; 1998 Jun; 17(6):470-3. PubMed ID: 9655536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.